Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4242826 | Magnetic Resonance Imaging Clinics of North America | 2009 | 9 Pages |
Abstract
There seems to be an association between exposure to intravenous gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF), a debilitating and sometimes fatal disease. This article addresses the relationship between GBCAs and NSF and answers some common questions. The policy deployed at Yale-New Haven Hospital for prevention of NSF and screening for patients at risk is delineated and discussed along with recommendations by the Food and Drug Administration.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Jeffrey C. MD, Phillip H. MD, PhD,